Maria Eugenia Alonso Ferrero
Immunogenecity Science Director,
Alexion Pharmaceuticals
Sessions
-
08-Sep-2026Theatre 1 (Zafir)Panel: The in vivo inflection: From breakthrough to clinical momentum, how far and how fast can this wave go?
-
08-Sep-2026Workshop Room (Rossini 1&2)Roundtable: Managing immunogenicity risk across the next generation of advanced therapies